Cargando…
Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation
Fibrosing cholestatic hepatitis (FCH) is an aggressive form of hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT), which frequently results in graft failure and death. Treatment of FCH remains challenging, and the optimal antiviral therapy is yet to be determined. Betwee...
Autores principales: | Issa, D., Eghtesad, B., Zein, N. N., Yerian, L., Cruise, M., Alkhouri, N., Adams, R., Hanouneh, I. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756263/ https://www.ncbi.nlm.nih.gov/pubmed/26889372 |
Ejemplares similares
-
Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir
por: Ascha, Mustafa, et al.
Publicado: (2015) -
Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus Infection
por: Hanouneh, I. A., et al.
Publicado: (2011) -
IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens
por: Hanouneh, I. A., et al.
Publicado: (2010) -
Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation
por: Khemichian, Saro, et al.
Publicado: (2015) -
Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation
por: Hori, Tomohide, et al.
Publicado: (2016)